Jan 27 (Reuters) - Abcellera Biologics Inc ABCL.O :
* ABCELLERA-DISCOVERED ANTIBODY, BAMLANIVIMAB, TO BE DEVELOPED WITH VIR-7831 FOR THE TREATMENT OF COVID-19
Jan 27 (Reuters) - Abcellera Biologics Inc ABCL.O :
* ABCELLERA-DISCOVERED ANTIBODY, BAMLANIVIMAB, TO BE DEVELOPED WITH VIR-7831 FOR THE TREATMENT OF COVID-19